Skip to content

A Controlled Clinical Trial To Evaluate The Effect Of Mudgadya Ghrit Uttarbasti and Apamarg Kshar Taila Uttarbasti in the Management of Adenomyosis Or Vataja Asrigdar

A Randomized Open Label Controlled Clinical Study to Evaluate the Efficacy of Mudgadya Ghrit Uttarbasti and Apamarg Kshar Taila Uttarbasti in the Management of Vataja Asrigdar w.s.r Adenomyosis - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092998
Enrollment
40
Registered
2025-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N719- Inflammatory disease of uterus, unspecified

Interventions

None listed

Sponsors

Institute for Ayurved Studies and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Married female Patients of age between 21 to 50years 2 Patients willing to participate in Clinical Trial 3 Patient having Heamoglobin greater than 7gm percent 4 Patients having symptoms of AUB or frothy bleeding or Menorrhagia with one all the following symptoms such as dysmenorrhea dyspareunia and known case of Adenomyosis confirmed by any diagnostic technique 5 Patients are Yogya for Uttarbasti procedure

Exclusion criteria

Exclusion criteria: 1 All pregnant women 2 Patients not willing for trial 3 Patient having Systemic Disease like Diabetes FBS greater than 125 mg per dl,Hypertension greater than 140 by 90mm of Hg,Severe Anemia Hb less than 7 gm percent 4 Patients having coagulation disorders, cardiovascular disorders, Cerebrovascular accidents 5 Patients suffering from Malignancy 6 Patient with congenital anamoly of reproductive tract 7 Acute inflammatory disease like Sexual Transmitted Disease like HIV, VDRL,HBsAg, HCV positive females 8 Patient Ayogya for Uttarbasti procedure

Design outcomes

Primary

MeasureTime frame
1 To improve the grading of MenorrhagiaTimepoint: Follow up will be done on 30,60,90,120 days

Secondary

MeasureTime frame
1 Improvement in the Heamoglobin level 2 To resolve MUSA Criteria for AdenomyosisTimepoint: Follow up will be done on 90 day & 1 more follow up on 120 day After completion of trail

Countries

India

Contacts

Public ContactDr Prajkta Gajanan Chaudhari

Institute for Ayurved Studies and Research

drjk67@gmail.com9896033056

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026